Results 171 to 180 of about 365,877 (337)

P1.09-10 Molecular Immunocytochemistry in Various NSCLC Samples Prepared as Non-Cell Block Cytology [PDF]

, 2019
Silvana Smojver‐Ježek, Božica Vrabec Branica, Vesna Šimić, Suzana Harabajsa, Ana Marušić, Sonja Badovinac, Sanja Pleština, Suzana Kukulj, Marko Jakopović   +8 more
openalex   +1 more source

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system [PDF]

, 2018
Achilefu, Samuel, Gu, Yueqiing, Li, Siwen, Liu, Yuxi, Rui, Yalan, Tang, Liping   +5 more
core   +2 more sources

MFAP4 promotes cell prognosis of non-small cell lung cancer through the inhibition of ferroptosis by FAK. [PDF]

Clin Exp Med
Li X, Xu C, Min Y, Zhu Y, Zhai Z.
europepmc   +1 more source

From mechanism to phenotype: What fits in a basket trial

Epilepsia, EarlyView.
Kette D. Valente
wiley   +1 more source

Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells

iMeta, EarlyView.
The detection of circulating tumor cells (CTCs) through liquid biopsy offers a non‐invasive approach for accurately monitoring cancer dissemination and evaluating therapeutic efficiency. However, their rarity and heterogeneity limit conventional tumor antigen labelling‐based methods in identifying and tracing CTCs.
Bin Ye, Zhen Wang, Yinqi Bai, Xu Zhang, Rui Zhang, Jingru Lian, Xuefei Liu, Yan Zhang, Zhiyuan Xu, Li Yang, Haiman Jin, Fang Chen, Zhihao Xie, Ping Zhou, Jun Tan, Shan Zeng, Changzheng Du, Yang Min, Xiaomin Ni, Jingxian Duan, Zhicheng Li, Hui Yang, Yunpeng Cai, Hongyan Wu, Catherine C. Liu, Jing Cai, Yi Lu, Jian Zhang, Hao Wu, Hairong Zheng, Longqi Liu, Xin Hong, Hao Yu   +32 more
wiley   +1 more source

LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axis. [PDF]

Clin Exp Metastasis
Zhang Y, Li X, Liu S, Xue Q, Meng P, Ge X, Zhao Q, Ma H.   +7 more
europepmc   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source

Multi-omics and network pharmacology identify IGFBP1 as an m6A-Epigenetic target of pueraria in NSCLC therapy. [PDF]

PLoS Comput Biol
Li R, Hu DM, Liu YL, Zhao W, Zhang YX, Qu YQ.   +5 more
europepmc   +1 more source

Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort

Interdisciplinary Medicine, EarlyView.
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li, Shun Wang, Guowei Zhao, Jiangtao Li, Xin Li, Bingning Wang, Yi Zhang, Mengfei Yao, Lei Guo, Jianming Ying, Wenbin Li   +10 more
wiley   +1 more source

Supplemental Figure 1 from Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC

Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A. Kiedrowski, Joseph C. Murray, Kristen A. Marrone, Susan C. Scott, Stefanie Houseknecht, Christina J. Falcon, Patrick Evans, Josephine Feliciano, Christine L. Hann, David S. Ettinger, Kellie N. Smith, Valsamo Anagnostou, Patrick M. Forde, Julie R. Brahmer, Benjamin Levy, Alexander Drilon, Vincent K. Lam   +20 more
openalex   +1 more source